Additional Stimulation of sGC on Top of Standard Treatment With ARB`s May Offer a New Therapeutic Approach for the Treatment of Diabetic Nephropathy Resistant to ARB Treatment Alone
BMC Pharmacology
doi 10.1186/1471-2210-11-s1-p1
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2011
Authors
Publisher
Springer Science and Business Media LLC